Cargando…

Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology

An increasing proportion of the population has acquired immunity through COVID-19 vaccination and previous SARS-CoV-2 infection, i.e., hybrid immunity, possibly affecting the risk of new infection. We aim to estimate the protective effect of previous infections and vaccinations on SARS-CoV-2 Omicron...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Gier, Brechje, Huiberts, Anne J., Hoeve, Christina E., den Hartog, Gerco, van Werkhoven, Henri, van Binnendijk, Rob, Hahné, Susan J. M., de Melker, Hester E., van den Hof, Susan, Knol, Mirjam J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412579/ https://www.ncbi.nlm.nih.gov/pubmed/37558656 http://dx.doi.org/10.1038/s41467-023-40195-z

Ejemplares similares

Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022
por: Huiberts, Anne J, et al.
Publicado: (2023)

Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022
por: Hoeve, Christina E, et al.
Publicado: (2023)

Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort study
por: Huiberts, Anne J., et al.
Publicado: (2023)

Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022
por: Andeweg, Stijn P, et al.
Publicado: (2023)

Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections
por: Andeweg, Stijn P., et al.
Publicado: (2022)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals
por: Knol, Mirjam J, et al.
Publicado: (2022)

Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022
por: de Gier, Brechje, et al.
Publicado: (2023)

Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022
por: van Iersel, Senna C.J.L., et al.
Publicado: (2023)

Out-of-season increase of puerperal fever with group A Streptococcus infection: a case–control study, Netherlands, July to August 2018
por: van den Boogaard, Jossy, et al.
Publicado: (2020)

Assessment of hybrid population immunity to SARS-CoV-2 following breakthrough infections of distinct SARS-CoV-2 variants by the detection of antibodies to nucleoprotein
por: den Hartog, Gerco, et al.
Publicado: (2023)

COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021
por: van Ewijk, Catharina E, et al.
Publicado: (2022)

Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis
por: Nic Lochlainn, Laura M, et al.
Publicado: (2019)

Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis
por: Nic Lochlainn, Laura M, et al.
Publicado: (2019)

Additional Evidence on Serological Correlates of Protection against Measles: An Observational Cohort Study among Once Vaccinated Children Exposed to Measles
por: Woudenberg, Tom, et al.
Publicado: (2019)

Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands
por: McDonald, Scott A., et al.
Publicado: (2021)

Mumps Vaccine Effectiveness Against Orchitis
por: Hahné, Susan, et al.
Publicado: (2012)

Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012
por: Sane, Jussi, et al.
Publicado: (2014)

Mumps transmission in social networks: a cohort study
por: Hahné, Susan, et al.
Publicado: (2017)

Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021
por: de Gier, Brechje, et al.
Publicado: (2021)

Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022
por: Eggink, Dirk, et al.
Publicado: (2022)

Disease burden of neonatal invasive Group B Streptococcus infection in the Netherlands
por: de Gier, Brechje, et al.
Publicado: (2019)

Measles Outbreak, the Netherlands, 2008
por: Hahné, Susan, et al.
Publicado: (2010)

The dynamics of scarlet fever in The Netherlands, 1906–1920: a historical analysis
por: McDonald, Scott A., et al.
Publicado: (2022)

Seroprevalence of Mumps in The Netherlands: Dynamics over a Decade with High Vaccination Coverage and Recent Outbreaks
por: Smits, Gaby, et al.
Publicado: (2013)

Occupation- and age-associated risk of SARS-CoV-2 test positivity, the Netherlands, June to October 2020
por: de Gier, Brechje, et al.
Publicado: (2020)

Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology
por: Woudenberg, Tom, et al.
Publicado: (2017)

The estimated disease burden of acute COVID-19 in the Netherlands in 2020, in disability-adjusted life-years
por: McDonald, Scott A., et al.
Publicado: (2022)

Associations Between Measures of Social Distancing and Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity: A Nationwide Population-based Study in the Netherlands
por: Vos, Eric R A, et al.
Publicado: (2021)

Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the national immunisation programme in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2019)

Mumps Serum Antibody Levels Before and After an Outbreak to Assess Infection and Immunity in Vaccinated Students
por: Gouma, Sigrid, et al.
Publicado: (2014)

Measles outbreak in a community with very low vaccine coverage, the Netherlands.
por: van den Hof, S, et al.
Publicado: (2001)

Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands
por: de Boer, Pieter T., et al.
Publicado: (2023)

Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?
por: van den Hoogen, Lotus L., et al.
Publicado: (2022)

Response to Letter to the Editor: Importance of considering high-risk behaviours in COVID-19 vaccine effectiveness estimates with observational studies
por: van Ewijk, Catharina E, et al.
Publicado: (2023)

Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study
por: Ohm, Milou, et al.
Publicado: (2021)

Gender-specific mortality in DTP-IPV- and MMR ± MenC-eligible age groups to determine possible sex-differential effects of vaccination: an observational study
por: Schurink-van’t Klooster, Tessa M, et al.
Publicado: (2015)

Asthma-Associated Long TSLP Inhibits the Production of IgA
por: van Heerden, Dorianne, et al.
Publicado: (2021)

Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study
por: den Hartog, Gerco, et al.
Publicado: (2021)

Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands
por: Tielemans, Susanne M A J, et al.
Publicado: (2017)

Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018
por: Knol, Mirjam J, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t8v1h169hgalrm43fk620p1n2h